Company intelligence / Profile preview
Recursion Pharmaceuticals
Salt Lake City, Utah, USAir.recursion.com ↗
- Ownership
- Public · RXRX
- Employees
- ~500
- Development stage
- Phase 2
01
Overview
Recursion Pharmaceuticals has developed one of the largest integrated tech-biology platforms for industrialized drug discovery. The company leverages massive proprietary biological and chemical datasets with machine learning to identify novel therapeutics rapidly. Its lead asset for cerebral cavernous malformation has reached Phase II trials—one of the first AI-discovered drugs to do so—and it maintains a broad pipeline across rare disease and oncology. The company recently merged with Exscientia to further expand its AI capabilities and pipeline breadth.
- Therapeutic areas
- OncologyRare DiseasesNeurology
- Modalities
- Small moleculesAI/ML-enabled drug discovery platforms
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Request access →03
Partnerships
Roche & Genentech ($12B neuroscience partnership)Bayer ($50M investment + fibrosis/onco collaboration)Sanofi GenzymeNVIDIA ($50M investment + cloud/A.I. collaboration)
04
Financials
- Market cap
- $1.8B
- Total revenue
- $7.7M
- Enterprise value
- $1.3B
Beyond the preview
Go deeper on Recursion Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Recursion Pharmaceuticals.